Cargando…

1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study

BACKGROUND: Spinal tuberculosis (TB) remains an important concern. Although spinal TB often has sequelae such as myelopathy after treatment, the predictive factors affecting such unfavorable outcomes are not yet known. Therefore, we investigated the clinical manifestations and predictors of unfavora...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho Kim, Jung, young Ahn, Jin, Jin Jeong, Su, su Ku, Nam, yong Choi, Jun, Keun Kim, Young, Yeom, Joon-Sup, Goo Song, Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808933/
http://dx.doi.org/10.1093/ofid/ofz360.1230
_version_ 1783461858314813440
author Ho Kim, Jung
young Ahn, Jin
Jin Jeong, Su
su Ku, Nam
yong Choi, Jun
Keun Kim, Young
Yeom, Joon-Sup
Goo Song, Young
author_facet Ho Kim, Jung
young Ahn, Jin
Jin Jeong, Su
su Ku, Nam
yong Choi, Jun
Keun Kim, Young
Yeom, Joon-Sup
Goo Song, Young
author_sort Ho Kim, Jung
collection PubMed
description BACKGROUND: Spinal tuberculosis (TB) remains an important concern. Although spinal TB often has sequelae such as myelopathy after treatment, the predictive factors affecting such unfavorable outcomes are not yet known. Therefore, we investigated the clinical manifestations and predictors of unfavorable treatment outcomes in patients with spinal TB. METHODS: We performed a multi-center retrospective cohort study of patients with spinal TB. The clinical features, comorbidities, laboratory data, imaging findings and treatment outcomes of the patients were analyzed. The unfavorable outcome was defined according to previous studies. The prognostic factors for unfavorable outcomes as the primary outcome were determined using multivariate logistic regression analysis and a linear mixed model were used to compare time course of inflammatory markers during treatment. RESULTS: A total of 185 patients (85 males and 100 females) were included. The mean age of the patients was 57.2 years. Of them, 115 underwent surgery during treatment, with a median treatment duration of 12 months. Fifty-nine patients had unfavorable outcomes. In multivariate regression analysis, the factors associated with unfavorable outcome were old age (odds ratio [OR], 2.51; P = 0.034), acid-fast bacilli (AFB) smear positivity in specimens obtained through biopsy (OR, 3.05; P = 0.039), and elevated erythrocyte sedimentation rate (ESR) at the end of treatment (OR, 3.85; P = 0.002). Patients with unfavorable outcomes had a significant trend toward higher ESR during treatment compared with patients with favorable outcome (P = 0.009). Duration of anti-TB and surgical treatment did not affect prognosis. CONCLUSION: Elevated ESR at the end of treatment could be used as a marker to identify spinal TB patients with a poor prognosis. Patients whose ESR are not normalized during treatment, as well as those with old age and AFB smear positivity, should be aware of unfavorable outcomes. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6808933
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68089332019-10-28 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study Ho Kim, Jung young Ahn, Jin Jin Jeong, Su su Ku, Nam yong Choi, Jun Keun Kim, Young Yeom, Joon-Sup Goo Song, Young Open Forum Infect Dis Abstracts BACKGROUND: Spinal tuberculosis (TB) remains an important concern. Although spinal TB often has sequelae such as myelopathy after treatment, the predictive factors affecting such unfavorable outcomes are not yet known. Therefore, we investigated the clinical manifestations and predictors of unfavorable treatment outcomes in patients with spinal TB. METHODS: We performed a multi-center retrospective cohort study of patients with spinal TB. The clinical features, comorbidities, laboratory data, imaging findings and treatment outcomes of the patients were analyzed. The unfavorable outcome was defined according to previous studies. The prognostic factors for unfavorable outcomes as the primary outcome were determined using multivariate logistic regression analysis and a linear mixed model were used to compare time course of inflammatory markers during treatment. RESULTS: A total of 185 patients (85 males and 100 females) were included. The mean age of the patients was 57.2 years. Of them, 115 underwent surgery during treatment, with a median treatment duration of 12 months. Fifty-nine patients had unfavorable outcomes. In multivariate regression analysis, the factors associated with unfavorable outcome were old age (odds ratio [OR], 2.51; P = 0.034), acid-fast bacilli (AFB) smear positivity in specimens obtained through biopsy (OR, 3.05; P = 0.039), and elevated erythrocyte sedimentation rate (ESR) at the end of treatment (OR, 3.85; P = 0.002). Patients with unfavorable outcomes had a significant trend toward higher ESR during treatment compared with patients with favorable outcome (P = 0.009). Duration of anti-TB and surgical treatment did not affect prognosis. CONCLUSION: Elevated ESR at the end of treatment could be used as a marker to identify spinal TB patients with a poor prognosis. Patients whose ESR are not normalized during treatment, as well as those with old age and AFB smear positivity, should be aware of unfavorable outcomes. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6808933/ http://dx.doi.org/10.1093/ofid/ofz360.1230 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Ho Kim, Jung
young Ahn, Jin
Jin Jeong, Su
su Ku, Nam
yong Choi, Jun
Keun Kim, Young
Yeom, Joon-Sup
Goo Song, Young
1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title_full 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title_fullStr 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title_full_unstemmed 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title_short 1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
title_sort 1366. prognostic factors for unfavorable outcomes of patients with spinal tuberculosis in a country with an intermediate tuberculosis burden: a multi-center cohort study
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808933/
http://dx.doi.org/10.1093/ofid/ofz360.1230
work_keys_str_mv AT hokimjung 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT youngahnjin 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT jinjeongsu 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT sukunam 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT yongchoijun 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT keunkimyoung 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT yeomjoonsup 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy
AT goosongyoung 1366prognosticfactorsforunfavorableoutcomesofpatientswithspinaltuberculosisinacountrywithanintermediatetuberculosisburdenamulticentercohortstudy